Catalyst Wire Dossier Catalyst Wire Dossier

Anti-VEGF therapy (head-to-head)

· Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-VEGF therapy (head-to-head), covering 2017-11-30 to 2017-11-30. Get the full timeline:

Most recent: Clinical Trial Update: Head to Head Study of Anti-VEGF Treatment. [Phase 4]

See pricing